CTLT 📈 Catalent - Overview

Catalent Inc, a global leader in the development and manufacturing of pharmaceutical and biopharmaceutical products, operates through two primary segments: Biologics and Pharma and Consumer Health. The company's Biologics segment is dedicated to providing comprehensive solutions for biologic proteins, cell and gene therapies, and other nucleic acid therapies, including formulation, development, and manufacturing services for pDNA, iPSCs, oncolytic viruses, and vaccines. Additionally, this segment offers analytical development and testing services for large molecules, as well as formulation, development, and manufacturing services for parenteral dose forms, such as vials, prefilled syringes, and cartridges.

The Pharma and Consumer Health segment, on the other hand, focuses on providing formulation, development, and manufacturing services for a wide range of products, including soft capsules for use in prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. This segment also offers clinical supply services, including manufacturing, packaging, storage, distribution, and inventory management for small-molecule drugs, protein-based biologics, and cell and gene therapies in clinical trials. Furthermore, the company provides pre-clinical screening, formulation, analytical development, and current good manufacturing practices manufacturing at clinical and commercial scale for various oral, nasal, inhaled, and topical dose forms, such as softgel capsules, Zydis fast-dissolve tablets, oral solid-dose formats, dry powder inhalers, and nasal delivery devices.

Catalent Inc also offers a range of specialized services, including FlexDirect direct-to-patient and FastChain demand-led clinical supply solutions, fill and finish operations for injectable products, and integrated development and product supply chain solutions. The company's client base is diverse, comprising biotechnology, pharmaceutical, and consumer health companies, as well as companies in other healthcare market segments, such as animal health and medical devices, and cosmetics industries. With a history dating back to 1933, Catalent Inc is headquartered in Somerset, New Jersey, and is listed on the New York Stock Exchange under the ticker symbol CTLT, with its common stock classified under the GICS Sub Industry: Pharmaceuticals.

As a leading player in the pharmaceutical and biopharmaceutical industry, Catalent Inc has established a strong online presence, with its website providing detailed information on its products and services, as well as its mission and values. The company's web URL is https://www.catalent.com, and its ISIN is US1488061029. With its comprehensive range of services and solutions, Catalent Inc is well-positioned to support the development and manufacturing needs of its clients, from early-stage development to commercial-scale production, and is committed to delivering high-quality products and services that meet the evolving needs of the healthcare industry.